Rallybio Corporation — Cash Flow (NASDAQ:RLYB) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities 45.53 M57.28 M60.27 M49.28 M 35 M Cash from investing activities 2.33 M112.17 M27.66 M33.49 M 41.77 M Cash from financing activities 82.97 M51.08 M143 K5.2 M 28 K Free cash flow 45.2 M57.23 M60.25 M49.28 M 35 M

Notizie

Lieber, CFO di Rallybio, vende azioni per 3.992 dollari

Lieber, Rallybio CFO, sells $3992 in shares

Rallybio reports positive phase 1 results for subcutaneous C5 inhibitor

Rallybio announces one-for-eight reverse stock split effective Feb 6

Upcoming Stock Splits This Week (February 2 to February 6) – Stay Invested - TipRanks.com

Rallybio implementerà un raggruppamento azionario 1:8 dal 6 febbraio

Rallybio to implement 1-for-8 reverse stock split effective February 6

Rallybio completes first cohort dosing in RLYB116 C5 inhibitor study

Here's Why Shares in Recursion Pharmaceuticals Surged Today

Recursion Pharmaceuticals stock soars after acquiring HPP treatment from Rallybio

Why Is Microcap Rallybio Stock Trading Higher On Tuesday? - Rallybio (NASDAQ:RLYB), Recursion Pharmaceuticals (NASDAQ:RXRX)

Rallybio sells HPP treatment program to Recursion for up to $25 million